Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Forman

Showing results (751-760 of 1,052) with videos related to

Pageof 106
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemiaS J Forman, G M Schmidt, A P Nademanee, et al.
Blood|April 1, 1987
Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignanciesK G Blume, S J Forman, M R O'Donnell, et al.
Blut|July 1, 1988
Fractionated total body irradiation and high dose cyclophosphamide: a preparative regimen for bone marrow transplantation for patients with hematologic malignancies in first complete remissionD S Snyder, D O Findley, S J Forman, et al.
Blood|June 4, 2008
Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimenGinna G Laport, Joseph C Alvarnas, Joycelynne M Palmer, et al.
Transplantation|March 1, 1993
Extended follow-up in 212 long-term allogeneic bone marrow transplant survivors. Issues of quality of lifeG M Schmidt, J C Niland, S J Forman, et al.
Transplantation|March 1, 1987
Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remissionK G Blume, S J Forman, D S Snyder, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 5, 2014
Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacyMahesh Jonnalagadda, Armen Mardiros, Ryan Urak, et al.
Transplantation|March 30, 2006
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantationLauri Burroughs, Marco Mielcarek, Wendy Leisenring, et al.
Leukemia & Lymphoma|August 19, 2024
The characterization and the impact of CSF pleocytosis during blinatumomab therapy for adult acute lymphoblastic leukemiaDat Ngo, Jose Tinajero, Joo Y Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2011
Phase II study of vorinostat for treatment of relapsed or refractory indolent non-Hodgkin's lymphoma and mantle cell lymphomaMark Kirschbaum, Paul Frankel, Leslie Popplewell, et al.
Pageof 106

Showing results (751-760 of 1,052) with videos related to

Sort By:
Pageof 106
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemiaS J Forman, G M Schmidt, A P Nademanee, et al.
Blood|April 1, 1987
Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignanciesK G Blume, S J Forman, M R O'Donnell, et al.
Blut|July 1, 1988
Fractionated total body irradiation and high dose cyclophosphamide: a preparative regimen for bone marrow transplantation for patients with hematologic malignancies in first complete remissionD S Snyder, D O Findley, S J Forman, et al.
Blood|June 4, 2008
Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimenGinna G Laport, Joseph C Alvarnas, Joycelynne M Palmer, et al.
Transplantation|March 1, 1993
Extended follow-up in 212 long-term allogeneic bone marrow transplant survivors. Issues of quality of lifeG M Schmidt, J C Niland, S J Forman, et al.
Transplantation|March 1, 1987
Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remissionK G Blume, S J Forman, D S Snyder, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 5, 2014
Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacyMahesh Jonnalagadda, Armen Mardiros, Ryan Urak, et al.
Transplantation|March 30, 2006
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantationLauri Burroughs, Marco Mielcarek, Wendy Leisenring, et al.
Leukemia & Lymphoma|August 19, 2024
The characterization and the impact of CSF pleocytosis during blinatumomab therapy for adult acute lymphoblastic leukemiaDat Ngo, Jose Tinajero, Joo Y Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2011
Phase II study of vorinostat for treatment of relapsed or refractory indolent non-Hodgkin's lymphoma and mantle cell lymphomaMark Kirschbaum, Paul Frankel, Leslie Popplewell, et al.
Pageof 106